What is the prevalence of Hajdu-Cheney Syndrome?

Hajdu-Cheney syndrome is an extremely rare genetic connective tissue disorder, with fewer than 100 cases documented in global medical literature. Due to its ultra-rare nature, precise prevalence and incidence rates remain unknown, though it is recognized as a condition that affects both males and females across diverse ethnic backgrounds.

Is Hajdu-Cheney syndrome considered rare or ultra-rare?

Hajdu-Cheney syndrome is classified as an ultra-rare disease. Because the condition is often underdiagnosed or misdiagnosed due to its complex spectrum of skeletal symptoms, there are no definitive epidemiological statistics regarding its true population prevalence. While the current medical literature contains fewer than 100 reported cases, the actual number of individuals living with Hajdu-Cheney syndrome is likely higher, as many patients may remain undiagnosed until adulthood when skeletal complications become more pronounced.

What is the age and gender distribution of Hajdu-Cheney syndrome?

Hajdu-Cheney syndrome presents across both pediatric and adult populations, though clinical recognition often occurs after the onset of progressive bone changes. Research indicates the following observations regarding its occurrence:

• Gender Distribution: There is no clear evidence of gender bias; Hajdu-Cheney syndrome appears to affect males and females with equal frequency.


• Age of Onset: While skeletal anomalies may be present at birth, symptoms such as acro-osteolysis (bone resorption in the fingers and toes) frequently progress during childhood and adolescence.


• Geographic/Ethnic Patterns: No specific geographic or ethnic clusters have been identified; the condition is reported globally.

Why is accurate data for Hajdu-Cheney syndrome difficult to obtain?

The primary challenge in mapping Hajdu-Cheney syndrome is the variability of its clinical presentation, which ranges from mild to severe skeletal involvement. Because Hajdu-Cheney syndrome is caused by mutations in the NOTCH2 gene, many patients may be misdiagnosed with more common skeletal dysplasias or osteoporosis. At DiseaseMaps.org, we have seen 5 individuals join our community, providing a vital, albeit small, real-world perspective on the lived experience of those managing this condition.

Next steps

• Consult a clinical geneticist to discuss genetic testing for the NOTCH2 gene.


• Coordinate care with a multidisciplinary team, including endocrinologists and orthopedic specialists.


• Connect with the Hajdu-Cheney syndrome community at DiseaseMaps.org to share experiences and find peer support.


• Stay informed about clinical research through the NIH Genetic and Rare Diseases (GARD) Information Center.

Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases (GARD) Information Center - Hajdu-Cheney Syndrome.


• Orphanet: Portal for rare diseases and orphan drugs (ORPHA:1879).


• OMIM (Online Mendelian Inheritance in Man): #102500 - Hajdu-Cheney Syndrome.